MetaCap

Propanc Biopharma (PPCB) vs Revelation Biosciences (REVB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Revelation Biosciences is the larger company by market cap ($2.0 million vs $1.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PPCB+256.93%REVB+322.65%
+459%+195%-69%
Oct 7, 20261 yearNov 20, 2026
PPCB+266.48%REVB+360.59%
+486%+209%-68%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PPCB versus REVB key metrics
MetricPPCBREVB
Share price$1.78$3.50
Market cap$1.87M$1.99M
1-day change+3.19%-5.15%
EPS (TTM)$-95.92$-99.96
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-18.86M$-8.91M
52-week high$315.00$40.60
52-week low$1.61$3.08
Distance from 52-week high-99.43%-91.38%
Analyst consensus—none
Avg. price target upside—+407.14%
Average volume188.66K12.49K
Shares outstanding1.05M569.06K
Employees28
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Propanc Biopharma

PPCB stock →

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Revelation Biosciences

REVB stock →

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.

Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees

PPCB vs REVB FAQ

Which is bigger, Propanc Biopharma or Revelation Biosciences?

Revelation Biosciences (REVB) is larger, with a market capitalization of $1.99M compared with $1.87M for Propanc Biopharma (PPCB).

Are Propanc Biopharma and Revelation Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons